Thor Medical ASA (FRA:8NN) ROE % Adjusted to Book Value: -3.00% (As of Dec. 2025)


FRA:8NN Thor Medical ASA FRA:8NN
21 GF Score
Price €0.38
! 2 Warning Signs
View Full Analysis

What is Thor Medical ASA ROE % Adjusted to Book Value?

Thor Medical ASA FRA:8NN +3.51% 21 ROE % Adjusted to Book Value is -3.00% as of Dec. 2025. GuruFocus rates FRA:8NN with a GF Score™ of 21/100. The stock has 2 warning signs investors should review.

Thor Medical ASA's ROE % for the quarter that ended in Dec. 2025 was -12.05%. Thor Medical ASA's PB Ratio for the quarter that ended in Dec. 2025 was 4.02. Thor Medical ASA's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 was -3.00%.

Thor Medical ASA ROE % Adjusted to Book Value Related Terms

Thor Medical ASA ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Thor Medical ASA's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Thor Medical ASA ROE % Adjusted to Book Value Chart

Thor Medical ASA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -17.53 -152.14 -15.38 -6.42 -3.63

Thor Medical ASA Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.13 -11.28 -9.03 -8.38 -3.00

FRA:8NN vs VRTX, REGN, ALNY: ROE % Adjusted to Book Value Comparison

For the Biotechnology subindustry, Thor Medical ASA's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Thor Medical ASA ROE % Adjusted to Book Value vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Thor Medical ASA's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Thor Medical ASA's ROE % Adjusted to Book Value falls into.


FRA:8NN
21GF Score
Thor Medical ASA FRA:8NN
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Thor Medical ASA ROE % Adjusted to Book Value Calculation

Thor Medical ASA's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-14.58% / 4.02
=-3.63%

Thor Medical ASA's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-12.05% / 4.02
=-3.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of -3.00% mean?
Thor Medical ASA (FRA:8NN) has a ROE % Adjusted to Book Value of -3.00% as of Dec. 2025. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Thor Medical ASA and its competitors.
Is Thor Medical ASA's ROE % Adjusted to Book Value too high?
Thor Medical ASA's current ROE % Adjusted to Book Value is -3.00%. Overall, Thor Medical ASA has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Thor Medical ASA's ROE % Adjusted to Book Value compare to VRTX and REGN?
Thor Medical ASA's ROE % Adjusted to Book Value of -3.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Biotechnology company?
A good ROE % Adjusted to Book Value depends on the Biotechnology industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Thor Medical ASA and its competitors. Thor Medical ASA's current ROE % Adjusted to Book Value is -3.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Thor Medical ASA stock overvalued right now?
Thor Medical ASA (FRA:8NN) has a current ROE % Adjusted to Book Value of -3.00%. The current ROE % Adjusted to Book Value is -3.00%. Thor Medical ASA's overall GF Score™ is 21/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Thor Medical ASA (FRA:8NN), the current ROE % Adjusted to Book Value is -3.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Thor Medical ASA Business Description

Other Exchanges TRMED:Norway0R6Y:UK
Address Drammensveien 167, Oslo, NOR, 0277
Thor Medical ASA is a Norway-based biopharmaceutical company. The company is a producer and supplier of alpha-particle emitters for cancer therapy. The production process is based on separation of natural occurring radioactive decay products from thorium. The Company is utilizing alpha-emitters in radiotherapy and cancer treatments using Pb-212, which can be produced from naturally occurring isotope Thorium-232 and Lead-212. It uses a proprietary production process that does not involve irradiation or nuclear reactors to produce alpha-emitting materials. These materials are used by radiopharmaceutical companies in the development of cancer therapies.
21GF Score

Get the complete analysis for FRA:8NN

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.38
Price